Timothy J. Arens
Net Worth

Last updated:

What is Timothy J. Arens net worth?

The estimated net worth of Mr. Timothy J. Arens is at least $9,195,325 as of 26 Nov 2024. He owns shares worth $2,626,869 as insider, has earned $276,456 from insider trading and has received compensation worth at least $6,292,000 in Surmodics, Inc..

What is the salary of Timothy J. Arens?

Mr. Timothy J. Arens salary is $572,000 per year as Senior Vice President of Fin. & Information Technology and Chief Financial Officer in Surmodics, Inc..

How old is Timothy J. Arens?

Mr. Timothy J. Arens is 58 years old, born in 1967.

What stocks does Timothy J. Arens currently own?

As insider, Mr. Timothy J. Arens owns shares in one company:

Company Title Shares Price per share Total value
Surmodics, Inc. (SRDX) Senior Vice President of Fin. & Information Technology and Chief Financial Officer 70,350 $37.34 $2,626,869

What does Surmodics, Inc. do?

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

SRDX logo
SRDX
Surmodics, Inc.
$37.34

Timothy J. Arens insider trading

Surmodics, Inc.

Mr. Timothy J. Arens has made 4 insider trades between 2014-2024, according to the Form 4 filled with the SEC. Most recently he sold 7,009 units of SRDX stock worth $276,456 on 26 Nov 2024.

The largest trade he's ever made was exercising 28,913 units of SRDX stock on 1 Aug 2016. As of 26 Nov 2024 he still owns at least 70,350 units of SRDX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 7,009 $39.44 $276,456
Option
Employee Stock Option (right to buy) 18,447 $33.2 $612,440
Option
Common Stock 18,447 $33.2 $612,440
Option
Common Stock 8,410 $60.07 $505,189
Option
Employee Stock Option (right to buy) 12,498 $23.95 $299,327
Option
Employee Stock Option (right to buy) 12,498 $23.95 $299,327
Option
Employee Stock Option (right to buy) 2,614 N/A N/A
Option
Common Stock 10,973 $20.64 $226,483
Option
Common Stock 10,973 N/A N/A
Option
Common Stock 15,926 N/A N/A
Option
Employee Stock Option 3,964 N/A N/A
Option
Employee Stock Option (right to buy) 11,962 N/A N/A
Sale
Common Stock 7,000 N/A N/A
Option
Common Stock 13,262 N/A N/A
Option
Employee Stock Option (right to buy) 13,262 $21.48 $284,801
Option
Employee Stock Option (right to buy) 13,262 N/A N/A
Option
Stock Option (right to buy) 4,000 N/A N/A
Option
Common Stock 28,913 N/A N/A
Sale
Common Stock 10,291 N/A N/A
Sale
Common Stock 10,330 N/A N/A
Option
Employee Stock Option (right to buy) 10,330 N/A N/A
Option
Common Stock 10,330 N/A N/A

Surmodics key executives

Surmodics, Inc. executives and other stock owners filed with the SEC:

  • Mr. Gary R. Maharaj (62) Chief Executive Officer, Pres & Director
  • Mr. Gordon S. Weber (62) Senior Vice President of Legal, Gen. Counsel & Sec.
  • Mr. Joseph J. Stich (60) Senior Vice President and GM of HR & In Vitro Diagnostics
  • Mr. Timothy J. Arens (58) Senior Vice President of Fin. & Information Technology and Chief Financial Officer
  • Ms. Teryl L. W. Sides (55) Senior Vice President of Product Devel. & Chief Marketing Officer